Skip to main content Accessibility help
×
Home
Hostname: page-component-59b7f5684b-n9lxd Total loading time: 0.374 Render date: 2022-09-24T19:12:11.278Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "displayNetworkTab": true, "displayNetworkMapGraph": false, "useSa": true } hasContentIssue true

The Effect of Apolipoprotein E ɛ4 (APOE E4) on Visuospatial Working Memory in Healthy Elders and Amnestic Mild Cognitive Impairment Patients: An Event-related Potentials Study

Published online by Cambridge University Press:  23 March 2020

L. Gu*
Affiliation:
Nanjing Zhongda Hospital, Southeast University, School of Medicine, Department of Neuropsychiatry, Nanjing, China

Abstract

Introduction

Previous studies provided inconsistent evidences for the effect of apolipoprotein E ɛ4 (APOE ɛ4) status on the visuospatial working memory (VSWM). Our study was the first investigation with event-related potential (ERP) to explore the effect of APOE ɛ4 on VSWM in healthy elders and aMCI patients.

Objective

The aim was to investigate the effect of APOE ɛ4 on VSWM with event-related potential (ERP) study in healthy elders and aMCI patients.

Methods

Thirty-nine aMCI patients (27 APOE ɛ4 non-carriers and 12 APOE ɛ4 carriers) and 43 their matched control (25 APOE ɛ4 non-carriers and 18 APOE ɛ4 carriers) performed an N-back task, a VSWM paradigm that manipulated the number of items to be stored in memory.

Results

Our study detected reduced accuracy and delayed mean correct response time in aMCI patients than healthy elders. P300 was elicited by VSWM and its amplitude was lower in aMCI patients at the central-parietal and parietal electrodes than healthy controls. In healthy elders, P300 amplitude declined prior to task performance change in APOE ɛ4 carriers than non-carriers. Regarding aMCI patients, P300 amplitude result revealed exacerbated VSWM deficits in APOE ɛ4 carriers than APOE ɛ4 non-carriers. Additionally, standardized low-resolution brain electromagnetic tomography analysis (s-LORETA) result showed enhanced brain activation in right parahippocampal gyrus during P300 time range in APOE ɛ4 carriers than non-carriers in aMCI patients (Fig. 1, Tables 1 and 2).

Conclusions

It demonstrated that P300 amplitude might serve as a biomarker for recognizing aMCI patients and contribute to early detection of worse VSWM in APOE ɛ4 carriers than non-carriers.

Disclosure of interest

The author has not supplied his/her declaration of competing interest.

Type
e-Poster walk: Old-age psychiatry
Copyright
Copyright © European Psychiatric Association 2017

Fig. 1 The sLORETA images showing statistical differences between aMCI– APOE ɛ4− and aMCI– APOE ɛ4+ group (3D-view and slice-view) in the P300 time-range. The three slice-view images below located the maximal difference between aMCI– APOE ɛ4− and aMCI– APOE ɛ4+ group (MNI coordinates x, y, z = 10, −35, 0). Negative difference was in blue color with reference of aMCI– APOE ɛ4+ group Abbreviations: aMCI: amnestic mild cognitive impairement; APOE: apoliprotein E; MNI: Montreal Neurological Institute; sLoreta: standardized low-resolution brain electromagnetic tomography analysis.

Table 1 Behavioral data (accuracy and response time) for healthy controls and a MCI patients with different APOE ɛ4 status.

Data are presented as mean ± standard deviation (SD). aMCI: amnestic mild cognitive impairement; APOE: apoliprotein E; HC: healthy controls.

aPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, HC-APOE ɛ4−vs. aMCI-APOE ɛ4−).

bPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, HC-APOE ɛ4+vs. aMCI-APOE ɛ4+).

Table 2 ERP data (P300 amplitude) for healthy controls and aMCI patients with different APOE ɛ4 status.

Data are presented as mean ± standard deviation (SD); aMCI: amnestic mild cognitive impairement; APOE: apoliprotein E; HC: healthy controls.

aPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, HC-APOE ɛ4− vs. HC-APOE ɛ4+).

b Post-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, aMCI-APOE ɛ4− vs. aMCI-APOE ɛ4+).

cPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, aMCI-APOE ɛ4− vs. HC-APOE ɛ4−).

dPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, aMCI-APOE ɛ4+ vs. HC-APOE ɛ4+).

Figure 0

Fig. 1 The sLORETA images showing statistical differences between aMCI– APOE ɛ4− and aMCI– APOE ɛ4+ group (3D-view and slice-view) in the P300 time-range. The three slice-view images below located the maximal difference between aMCI– APOE ɛ4− and aMCI– APOE ɛ4+ group (MNI coordinates x, y, z = 10, −35, 0). Negative difference was in blue color with reference of aMCI– APOE ɛ4+ group Abbreviations: aMCI: amnestic mild cognitive impairement; APOE: apoliprotein E; MNI: Montreal Neurological Institute; sLoreta: standardized low-resolution brain electromagnetic tomography analysis.

Figure 1

Table 1 Behavioral data (accuracy and response time) for healthy controls and a MCI patients with different APOE ɛ4 status.Data are presented as mean ± standard deviation (SD). aMCI: amnestic mild cognitive impairement; APOE: apoliprotein E; HC: healthy controls.aPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, HC-APOE ɛ4−vs. aMCI-APOE ɛ4−).bPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, HC-APOE ɛ4+vs. aMCI-APOE ɛ4+).

Figure 2

Table 2 ERP data (P300 amplitude) for healthy controls and aMCI patients with different APOE ɛ4 status.Data are presented as mean ± standard deviation (SD); aMCI: amnestic mild cognitive impairement; APOE: apoliprotein E; HC: healthy controls.aPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, HC-APOE ɛ4− vs. HC-APOE ɛ4+).b Post-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, aMCI-APOE ɛ4− vs. aMCI-APOE ɛ4+).cPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, aMCI-APOE ɛ4− vs. HC-APOE ɛ4−).dPost-hoc tests by Bonferroni's analysis further revealed the source of ANCOVA difference (P < 0.05, aMCI-APOE ɛ4+ vs. HC-APOE ɛ4+).

Submit a response

Comments

No Comments have been published for this article.
You have Access
1
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

The Effect of Apolipoprotein E ɛ4 (APOE E4) on Visuospatial Working Memory in Healthy Elders and Amnestic Mild Cognitive Impairment Patients: An Event-related Potentials Study
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

The Effect of Apolipoprotein E ɛ4 (APOE E4) on Visuospatial Working Memory in Healthy Elders and Amnestic Mild Cognitive Impairment Patients: An Event-related Potentials Study
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

The Effect of Apolipoprotein E ɛ4 (APOE E4) on Visuospatial Working Memory in Healthy Elders and Amnestic Mild Cognitive Impairment Patients: An Event-related Potentials Study
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *